Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04700033 · ClinicalTrials.gov registry record · NA
Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04700033 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 23 participants.
The verdict
NCT04700033, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The aim of this study is to provide critical information about the efficacy of Immersive Virtual Reality (IVR) to decrease the experience of neuropathic pain in the upper and lower extremities of people with a spinal cord injury.
Interventions
- DEVICE Somatic IVR (sIVR)
- DEVICE Distractive IVR (dIVR)
- DEVICE Control IVR (cIVR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-07-17 |
| Est. Completion | 2022-05-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04700033
The ClinicalTrials.gov registry entry for NCT04700033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Somatic IVR (sIVR) is the first listed.
NCT04700033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04700033 about?
NCT04700033 is a clinical study titled "Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial". The aim of this study is to provide critical information about the efficacy of Immersive Virtual Reality (IVR) to decrease the experience of neuropathic pain in the upper and lower extremities of people with a spinal cord injury.
What is the current status of trial NCT04700033?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2019-07-17. Estimated completion is 2022-05-05.
What interventions are being tested in trial NCT04700033?
The interventions under investigation include: Somatic IVR (sIVR) (DEVICE), Distractive IVR (dIVR) (DEVICE), Control IVR (cIVR) (DEVICE).
Who is sponsoring clinical trial NCT04700033?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.